Definium Therapeutics, Inc. · NASDAQ:DFTX
Sullivan Mark received 125,000 Definium Therapeutics, Inc. shares as an award (Form 4)
Traded Sep 14, 2026 · Filed Sep 14, 2026
On Sep 14, 2026, Sullivan Mark (Chief Legal Officer) received 125,000 Definium Therapeutics, Inc. shares as an award, leaving 508,279 shares. Filed Sep 14, 2026 (Form 4).
- Awarded
- 125,000 shares
- Holding after
- 508,279 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Shares | Award | 125,000 | 508,279 | Direct |
Source
Related
- Definium Therapeutics, Inc.
- Sullivan Mark
- Definium Therapeutics, Inc. shareholders
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Sullivan Mark · Aug 12, 2026
- Form 4 · Sullivan Mark · Jun 26, 2026
- Form 4 · Sullivan Mark · Jun 22, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 29, 2026
- Form 4 · Krebs Andreas · Sep 18, 2026